IBDEI2FW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38969,2)
 ;;=^5009055
 ;;^UTILITY(U,$J,358.3,38970,0)
 ;;=L03.322^^152^1990^15
 ;;^UTILITY(U,$J,358.3,38970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38970,1,3,0)
 ;;=3^Acute Lymphangitis of Back
 ;;^UTILITY(U,$J,358.3,38970,1,4,0)
 ;;=4^L03.322
 ;;^UTILITY(U,$J,358.3,38970,2)
 ;;=^5009056
 ;;^UTILITY(U,$J,358.3,38971,0)
 ;;=L03.323^^152^1990^16
 ;;^UTILITY(U,$J,358.3,38971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38971,1,3,0)
 ;;=3^Acute Lymphangitis of Chest Wall
 ;;^UTILITY(U,$J,358.3,38971,1,4,0)
 ;;=4^L03.323
 ;;^UTILITY(U,$J,358.3,38971,2)
 ;;=^5009057
 ;;^UTILITY(U,$J,358.3,38972,0)
 ;;=L03.324^^152^1990^18
 ;;^UTILITY(U,$J,358.3,38972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38972,1,3,0)
 ;;=3^Acute Lymphangitis of Groin
 ;;^UTILITY(U,$J,358.3,38972,1,4,0)
 ;;=4^L03.324
 ;;^UTILITY(U,$J,358.3,38972,2)
 ;;=^5009058
 ;;^UTILITY(U,$J,358.3,38973,0)
 ;;=L03.325^^152^1990^24
 ;;^UTILITY(U,$J,358.3,38973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38973,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,38973,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,38973,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,38974,0)
 ;;=L03.326^^152^1990^30
 ;;^UTILITY(U,$J,358.3,38974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38974,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,38974,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,38974,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,38975,0)
 ;;=L03.329^^152^1990^29
 ;;^UTILITY(U,$J,358.3,38975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38975,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,38975,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,38975,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,38976,0)
 ;;=L08.9^^152^1990^171
 ;;^UTILITY(U,$J,358.3,38976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38976,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,38976,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,38976,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,38977,0)
 ;;=L11.0^^152^1990^10
 ;;^UTILITY(U,$J,358.3,38977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38977,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,38977,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,38977,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,38978,0)
 ;;=L20.0^^152^1990^91
 ;;^UTILITY(U,$J,358.3,38978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38978,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,38978,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,38978,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,38979,0)
 ;;=L20.81^^152^1990^88
 ;;^UTILITY(U,$J,358.3,38979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38979,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,38979,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,38979,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,38980,0)
 ;;=L20.82^^152^1990^153
 ;;^UTILITY(U,$J,358.3,38980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38980,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,38980,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,38980,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,38981,0)
 ;;=L20.84^^152^1990^165
 ;;^UTILITY(U,$J,358.3,38981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38981,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,38981,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,38981,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,38982,0)
 ;;=L20.89^^152^1990^86
